Last-Hope heart device made available for critically ill patients
NCT ID NCT07421557
Summary
This is not a standard clinical trial. It's an 'expanded access' program that allows doctors to request a special heart device called the Occlutech AFR for patients with severe pulmonary hypertension who have no other treatment options. The device is designed to help control the disease by creating a small opening between the heart's upper chambers to relieve pressure. Each request must be approved by the FDA and a hospital review board on a case-by-case basis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new related studies are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Individual Sites Across the U.S.
AVAILABLEMaple Grove, Minnesota, 55369, United States